Bicara Therapeutics Inc. (BCAX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $280.0K | +294.4% |
| 2024 | $71.0K | -87.9% |
| 2023 | $586.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $280.0K | +294.4% |
| 2024 | $71.0K | -87.9% |
| 2023 | $586.0K | — |